The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors
Open accessAbstract
Significance Understanding of myelin diseases and development of new treatment options are at least partly hampered by the limited availability of human oligodendrocytes. Induced pluripotent stem cells (iPSC) may be an ideal tool to circumvent this problem; however, rapid and efficient protocols to generate oligodendrocytes from human iPSC are currently lacking. The induction of the transcription factors SOX10, OLIG2, and NKX6.2 in iPSC-derived neural progenitors accelerates oligodendroglial differentiation significantly resulting in up to 70% of O4 + oligodendrocytes within 28 d. These oligodendrocytes myelinate the CNS during development and after demyelination, and are suitable for pharmacological screens and disease modeling. The strategy presented herein will markedly facilitate the studying of human myelin diseases and the development of screening platforms for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic sources, such as fibroblasts or peripheral blood cells, can be reprogrammed into iPS cells or directly converted into neural lineages, offering versatile platforms to model MS, PMD and other neuroinflammatory or demyelinating disorders48–55.”
From From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics (2026) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes were derived from iPSCs as previously described [17].”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Lu, Q. R., Yuk, D.-I., Alberta, J., Zhu, Z.-M., Pawlitzky, I., Chan, J., McMahon, A., Stiles, C., & Rowitch, D. H. (2000) · Neuron · doi:10.1016/s0896-6273(00)80897-1 · Cited by 883
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Mei, F., Fancy, S. P. J., Shen, Y. A., Niu, J., Zhao, C., Presley, B., Miao, E., Lee, S., Mayoral, S. R., Redmond, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3618 · Cited by 595
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586
A regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Reinhardt, P., Glatza, M., Hemmer, K., Tsytsyura, Y., Thiel, C. S., Höing, S., Moritz, S., Parga, J. A., Wagner, L., Bruder, J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059252 · Cited by 461
Self-citationGhetti, B. F., Oblak, A. L., Boeve, B. F., Johnson, K. A., Dickerson, B. C., & Goedert, M. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12213 · Cited by 458
A culture system to study oligodendrocyte myelination processes using engineered nanofibers
Lee, S., Leach, M. K., Redmond, S., Chong, S. Y. C., Mellon, S. H., Tuck, S. J., Feng, Z. Q., Corey, J. M., & Chan, J. R. (2012) · Nature Methods · doi:10.1038/nmeth.2105 · Cited by 455
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 258
iPSC modeling of rare pediatric disorders
Freel, B. A., Sheets, J. N., & Francis, K. R. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108533 · Cited by 20
OCT4-induced oligodendrocyte progenitor cells promote remyelination and ameliorate disease
Yun, W., Choi, K., Hwang, I.-S., Zheng, J., Park, M., Hong, W., Jang, A.-Y., Kim, J. H., Choi, W., Kim, D., et al. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-021-00199-z · Cited by 21
Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-023-00310-5 · Cited by 20
Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo
Krut’, V. G., Kalinichenko, A. L., Maltsev, D. I., Jappy, D., Shevchenko, E. K., Podgorny, O. V., & Belousov, V. V. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102600 · Cited by 17
Using MS induced pluripotent stem cells to investigate MS aetiology
Fortune, A. J., Fletcher, J. L., Blackburn, N. B., & Young, K. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103839 · Cited by 17
The in vivo timeline of differentiation of engrafted human neural progenitor cells
Vogel, S. N., Schäfer, C., Heß, S., Folz‐Donahue, K., Nelles, M., Minassian, A., Schwarz, M. K., Kukat, C., Ehrlich, M., Zaehres, H., et al. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101429 · Cited by 17
Self-citationAre oligodendrocytes bystanders or drivers of Parkinson’s disease pathology?
Campos, J. M. S., Burbulla, L., & Jäkel, S. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3002977 · Cited by 13
Neuroinflammation: An Oligodendrocentric View
Festa, L. K., Jordan‐Sciutto, K. L., & Grinspan, J. B. (2025) · Glia · doi:10.1002/glia.70007 · Cited by 18
From Cells to Organs: The Present and Future of Regenerative Medicine
Wang, Y., & Jang, Y.-Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_657 · Cited by 21
Human stem cell transplantation models of Alzheimer’s disease
Ifediora, N., Canoll, P., & Hargus, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1354164 · Cited by 18
Self-citationIdentity and Maturity of iPSC-Derived Oligodendrocytes in 2D and Organoid Systems
Zeldich, E., & Rajkumar, S. (2024) · Cells · doi:10.3390/cells13080674 · Cited by 17
Galichet, C., Clayton, R. W., & Lovell-Badge, R. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.673132 · Cited by 16
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
Kühn, R., Mahajan, A., Canoll, P., & Hargus, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.766773 · Cited by 18
Self-citationGrekhnev, D. A., Kaznacheyeva, E. V., & Vigont, V. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020624 · Cited by 16
Ultrahigh field imaging of myelin disease models: Toward specific markers of myelin integrity?
Petiet, A., Adanyeguh, I. M., Aigrot, M., Poirion, É., Nait‐Oumesmar, B., Santin, M. D., & Stankoff, B. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24598 · Cited by 19
Sarrazin, N., Chavret-Reculon, E., Bachelin, C., Felfli, M., Arab, R., Gilardeau, S., Brazhnikova, E., Dubus, E., Yahia Cherif, L., Lorenceau, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115973119 · Cited by 15
Self-citationPluripotent stem cell strategies for rebuilding the human brain
Limone, F., Klim, J. R., & Mordes, D. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1017299 · Cited by 15
Shim, G., Romero-Morales, A. I., Sripathy, S. R., & Maher, B. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1322813 · Cited by 16
Nishri, Y., Hampton, D. W., Ben-Shushan, E., Fainstein, N., Magnani, D., Aharonowiz, M., Reubinoff, B. E., Chandran, S., & Ben‐Hur, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01802-7 · Cited by 15
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Klimmt, J., Dannert, A., & Paquet, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.008 · Cited by 16
Kroehne, V., Tsata, V., Marrone, L., Froeb, C., Reinhardt, S., Gompf, A., Dahl, A., Sterneckert, J. L., & Reimer, M. M. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00284 · Cited by 15
Self-citationBaranes, K., Hastings, N., Rahman, S. M. J., Poulin, N., Tavares, J. M., Kuan, W., Syed, N., Kunz, M., Blighe, K., Belgard, T. G., et al. (2023) · Glia · doi:10.1002/glia.24372 · Cited by 16
Martínez-Curiel, R., Jansson, L., Tsupykov, O., Avaliani, N., Aretio-Medina, C., Hidalgo, I., Monni, E., Bengzon, J., Skibo, G. G., Lindvall, O., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.04.010 · Cited by 14
Hansen, M. G., Tornero, D., Canals, I., Ahlenius, H., & Kokaia, Z. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9007-8_6 · Cited by 13
Dwivedi, S., Choudhary, P., Gupta, A., & Singh, S. (2023) · Biochimie · doi:10.1016/j.biochi.2023.02.012 · Cited by 14
Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models
Rõlova, T., Lehtonen, Š., Goldsteins, G., Kettunen, P., & Koıstınaho, J. (2020) · Stem Cells · doi:10.1002/stem.3309 · Cited by 14
Mozafari, S., Deboux, C., Laterza, C., Ehrlich, M., Kuhlmann, T., Martino, G., & Baron‐Van Evercooren, A. (2021) · Glia · doi:10.1002/glia.23950 · Cited by 13
Self-citationLeveraging the Genetic Diversity of Human Stem Cells in Therapeutic Approaches
Tegtmeyer, M., & Nehme, R. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167221 · Cited by 12
Watson, L. A., & Meharena, H. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1198129 · Cited by 13
Modelling multiple sclerosis using induced pluripotent stem cells
Martínez-Larrosa, J., Matute‐Blanch, C., Montalbán, X., & Comabella, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577425 · Cited by 14
Promoting exogenous repair in multiple sclerosis: myelin regeneration
Bezukladova, S., Genchi, A., Panina‐Bordignon, P., & Martino, G. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001062 · Cited by 14
Mozafari, S., & Baron-Van Evercooren, A. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.09.011 · Cited by 13
Self-citationGeneration of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion
Tanabe, K., Nobuta, H., Yang, N., Ang, C. E., Huie, P., Jordan, S., Oldham, M. C., Rowitch, D. H., & Wernig, M. (2022) · Development · doi:10.1242/dev.199723 · Cited by 13
Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias
Putka, A. F., Mato, J. P., & McLoughlin, H. S. (2023) · Cells · doi:10.3390/cells12040601 · Cited by 12
Piscopo, V. E. C., Chapleau, A., Blaszczyk, G. J., Sirois, J., You, Z., Soubannier, V., Chen, C. X. ‐., Bernard, G., Antel, J. P., & Durcan, T. M. (2024) · Glia · doi:10.1002/glia.24524 · Cited by 14
Self-citationRaabe, F. J., Stephan, M., Waldeck, J. B., Huber, V., Demetriou, D., Kannaiyan, N. R., Galinski, S., Glaser, L. V., Wehr, M. C., Ziller, M. J., et al. (2022) · Cells · doi:10.3390/cells11020241 · Cited by 11
Radoszkiewicz, K., Hribljan, V., Isaković, J., Mitrečić, D., & Sarnowska, A. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114353 · Cited by 12
Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells?
Prytkova, I., Goate, A., Hart, R. P., & Slesinger, P. A. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13811 · Cited by 12
Canals, I., Quist, E., & Ahlenius, H. (2021) · Cellular Reprogramming · doi:10.1089/cell.2021.0045 · Cited by 11
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
Guo, X., Wang, X., Wang, J., Ma, M., & Ren, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083774 · Cited by 15
Neyrinck, K., & García‐León, J. A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1601-7_11 · Cited by 11
Cell transplantation to repair the injured spinal cord
Hall, A. A., Fortino, T. A., Spruance, V. M., Niceforo, A., Harrop, J. S., Phelps, P. E., Priest, C. A., Zholudeva, L. V., & Lane, M. A. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.09.008 · Cited by 12
Clinical implications of myelin regeneration in the central nervous system
McMurran, C. E., Kodali, S., Young, A. M. H., & Franklin, R. J. M. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1421458 · Cited by 11
The K2P‐channel TASK1 affects Oligodendroglial differentiation but not myelin restoration
Albrecht, S., Korr, S., Nowack, L., Narayanan, V., Starost, L. J., Stortz, F., Araúzo-Bravo, M. J., Meuth, S. G., Kuhlmann, T., & Hundehege, P. (2019) · Glia · doi:10.1002/glia.23577 · Cited by 12
Self-citationAssetta, B., Tang, C., Bian, J., O'Rourke, R., Connolly, K., Brickler, T., Chetty, S., & Huang, Y.-W. A. (2020) · Journal of Visualized Experiments · doi:10.3791/61778 · Cited by 11
Direct Conversion to Achieve Glial Cell Fates: Oligodendrocytes and Schwann Cells
Yun, W., Kim, Y. J., & Lee, G. (2022) · International Journal of Stem Cells · doi:10.15283/ijsc22008 · Cited by 11
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Pistollato, F., Bal-Price, A., Coecke, S., Parvatam, S., Pamies, D., Czysz, K., Hao, J., Kee, K., Teo, A. K. K., Niu, S., et al. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.06.003 · Cited by 10
Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11
Papadopoulou, M. A., Rogdakis, T., Charou, D., Peteinareli, M., Ntarntani, K., Gravanis, A., Chanoumidou, K., & Charalampopoulos, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411683 · Cited by 10
Young, J. E., & Goldstein, L. S. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_6 · Cited by 10
Sharifi-Kelishadi, M., Zare, L., Fathollahi, Y., & Javan, M. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02206-6 · Cited by 10
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 9
Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease
Asiamah, E. A., Guo, R., Kong, D., Feng, B., He, J., Zhang, W., Liu, X., Du, X., Ma, Z., Liu, B., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0065 · Cited by 9
Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models
Bigarreau, J., Rouach, N., Perrier, A. L., Mouthon, F., & Charvériat, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031684 · Cited by 10
Koppenhafer, S. L., Goss, K. L., Voigt, E. M., Croushore, E. E., Terry, W. W., Ostergaard, J., Gordon, P. M., & Gordon, D. J. (2022) · Oncogene · doi:10.1038/s41388-022-02310-0 · Cited by 9
Hoch-Kraft, P., Trotter, J., & Gonsior, C. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02763-y · Cited by 11
Interplay Between Aging and Glial Cell Dysfunction: Implications for CNS Health
García‐Domínguez, M. (2025) · Life · doi:10.3390/life15101498 · Cited by 12
Nanomaterial payload delivery to central nervous system glia for neural protection and repair
Saksena, J., Hamilton, A. E., Gilbert, R. J., & Zuidema, J. M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1266019 · Cited by 9
Levy, M. J. F., Garcia-Diaz, B., Sedel, F., Baron-Van Evercooren, A., & Mozafari, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415733 · Cited by 7
Self-citationLohrasbi, F., Ghasemi‐Kasman, M., Soghli, N., Ghazvini, S., Vaziri, Z., Abdi, S., & Darban, Y. M. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230220150010 · Cited by 8
Zamponi, M., Mollica, P. A., Khodour, Y., Bjerring, J. S., Bruno, R. D., & Sachs, P. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1258993 · Cited by 7
HiPSC-derived 3D neural models reveal neurodevelopmental pathomechanisms of the Cockayne Syndrome B
Kapr, J., Scharkin, I., Ramachandran, H., Westhoff, P., Pollet, M., Dangeleit, S., Brockerhoff, G., Rossi, A., Koch, K., Krutmann, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05406-w · Cited by 10
Jung‐Klawitter, S., & Opladen, T. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0225-9 · Cited by 8
Ma, L., Mei, Y., Xu, P., Cheng, Y., You, Z., Ji, X., Zhuang, D., Zhou, W., Chen, Y., & Xiong, M. (2021) · iScience · doi:10.1016/j.isci.2022.105172 · Cited by 7
Michalski, C., & Wen, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1291115 · Cited by 7
Yalcin, E. B., Tong, M., & de la Monte, S. M. (2018) · Journal of Drug and Alcohol Research · doi:10.4303/jdar/236065 · Cited by 6
A novel human organoid model system reveals requirement of TCF4 for oligodendroglial differentiation
Furlanetto, F., Flegel, N., Kremp, M., Spear, C., Fröb, F., Alfonsetti, M., Bohl, B., Krumbiegel, M., Turan, S., Reis, A., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202403102 · Cited by 7
Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming
Legault, E. M., Bouquety, J., & Drouin‐Ouellet, J. (2022) · Cellular Reprogramming · doi:10.1089/cell.2021.0172 · Cited by 7
Xu, J., Yang, Z., Wang, R., He, F., Yan, R., Zhang, Y., Yu, L., Deng, W., & Nie, Y. (2022) · Communications Biology · doi:10.1038/s42003-022-04043-y · Cited by 6
Ji, Y., McLean, J. L., & Xu, R. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01189-z · Cited by 8
Chang, M., Waldeck, J. B., Stephan, M., Kannaiyan, N. R., de Almeida, V., Boudriot, E., Karali, T., Röll, L., Fischer, L. E., Demetriou, D., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03509-x · Cited by 6
Mouhi, S., Pio, T., & Andersen, J. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.11.003 · Cited by 7
Choi, J. J., Svaren, J. P., & Wang, D. (2025) · Communications Biology · doi:10.1038/s42003-025-07570-6 · Cited by 8
Epperly, M. W., Fisher, R., Rigatti, L. H., Watkins, S. C., Zhang, X., HOU, W., Shields, D. S., Franicola, D., Bayır, H., Wang, H., et al. (2019) · In Vivo · doi:10.21873/invivo.11526 · Cited by 5
Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids
Yun, W., Kim, I. Y., Song, G., & You, S. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0455 · Cited by 5
Verma, I., & Seshagiri, P. B. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10851-6 · Cited by 4
Gacem, N., Bezukladova, S., Windener, F., Karam, T., Ottoboni, L. K., Brambilla, E., Ruffini, F., Soman, K., García-Díaz, B., Levy, M. J. F., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.ads0633 · Cited by 6
Self-citationYang, Z., Teaney, N. A., Buttermore, E. D., Şahin, M., & Saber, W. A. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1524577 · Cited by 4
Dissection of Neurochemical Pathways Across Complexity and Scale
Abbondanza, A., Kim, N., Lima‐Filho, R. A. S., Amin, A., Anversa, R. G., Almeida, F. B., Cardozo, P. L., Carello‐Collar, G., Carsana, E. V., Folarin, R. O., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70160 · Cited by 4
Gao, H. Z., Guo, Y., Biswas, S., Li, J., Zhang, H., Chen, Z., & Deng, W. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10405-0 · Cited by 4
Cell‐based experimental strategies for myelin repair in multiple sclerosis
Borda, M., Aquino, J. B., & Mazzone, G. L. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25129 · Cited by 4
Three-dimensional models of human brain development
Tobon, A., Caporale, N., Trattaro, S., & Testa, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814085-7.00011-8 · Cited by 4
Yokosawa, R., Mazur, R. A., Wilson, K. A., Lee, J. H., Showalter, N. W., Lampe, K. J., & VandeVord, P. J. (2025) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2025.100126 · Cited by 3
The Interaction between Oligodendrocytes and Aβ in Alzheimer's Disease
Wang, W., Huang, X., Xu, Z., & Yu, C. (2025) · Current Alzheimer Research · doi:10.2174/0115672050401966250625171338 · Cited by 3
Chapleau, A., Perrier, S., Durcan, T. M., & Bernard, G. (2025) · npj Genomic Medicine · doi:10.1038/s41525-025-00533-0 · Cited by 3
Stem and progenitor cell-based therapy of myelin disorders
Goldman, S. A., Franklin, R. J. M., & Osório, M. J. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00015-0 · Cited by 3
Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment
Yang, Z., Gong, M., Yang, C., Chen, C., & Zhang, K. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_697 · Cited by 3
Kremp, M., Aberle, T., Sock, E., Bohl, B., Hillgärtner, S., Winkler, J., & Wegner, M. (2024) · Glia · doi:10.1002/glia.24538 · Cited by 3
From Cells to Selves and Back: Human Neurodiversity at Single-Cell Resolution
Lessi, M., Caporale, N., & Testa, G. (2025) · Physiology · doi:10.1152/physiol.00010.2025 · Cited by 3
A Guide to Understanding “State-of-the-Art” Basic Research Techniques in Anesthesiology
Obal, D., Wu, S., McKinstry-Wu, A. R., & Tawfik, V. L. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004801 · Cited by 3
Specification of oligodendrocytes
Wegner, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00034-5 · Cited by 3
Oligodendroglia Generated From Adult Rat Adipose Tissue by Direct Cell Conversion
Vellosillo, L., Pascual-Guerra, J., Muñoz, M. P., Rodríguez‐Navarro, J. A., González‐Nieto, D., Barrio, L. C., Toledo-Lobo, M. V., & Paı́no, C. L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.741499 · Cited by 4
Dehestani, M., Kessler, W., Karmali, N., Sun, W., Volos, P., Tsitkov, S., Dhingra, A., Rodrı́guez-Nieto, S., Tietz, J., Schafflick, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.01.601392 · Cited by 3
Self-citationEfficient generation of human oligodendrocyte grafts that restore myelin in adult human brain tissuePreprint
Martínez-Curiel, R., Tsupykov, O., Rincón-Cerrada, P., Khani, A.-M. A., Sharma, Y., Hernandez, D. M., Monni, E., Adami, A., Savchenko, E., Rodríguez, L. R., et al. (2025) · Research Square · doi:10.1101/2025.02.28.640804 · Cited by 2
From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics
Karbalaee, M., Lin, A., Peruzzotti-Jametti, L., Pluchino, S., & Mozafari, S. (2026) · Lab Animal · doi:10.1038/s41684-026-01725-6 · Cited by 2
Self-citationTsarouchas, T. M., Zoupi, L., Williams, A., & Gibson, E. M. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.103609 · Cited by 2
Ding, C., Pan, Z., Yan, X., Zhou, R., Li, H., Chen, L., Wang, Y., & Zhang, Y. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003100 · Cited by 2
McDaid, G., Vanek, J., Cromer, B. A., & Sümer, H. (2025) · Biomedicines · doi:10.3390/biomedicines13112783 · Cited by 2
Advanced Cellular Models for Neurodegenerative Diseases and PFAS-Related Environmental Risks
Rotondo, D., Lagostena, L., Magnelli, V., & Dondero, F. (2025) · NeuroSci · doi:10.3390/neurosci6040125 · Cited by 3
Gu, J., Rollo, B., Liu, Z., O'Brien, T. J., Kwan, P., Cromer, B. A., & Sümer, H. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-04917-6 · Cited by 2
Metadata
- Authors
- Ehrlich, M., Mozafari, S., Glatza, M., Starost, L., Velychko, S., Hallmann, A.-L., Cui, Q.-L., Schambach, A., Kim, K.-P., Bachelin, C., Marteyn, A., Hargus, G., Johnson, R. M., Antel, J., Sterneckert, J., Zaehres, H., Schöler, H. R., Baron-Van Evercooren, A., & Kuhlmann, T.
- Affiliations
- University Hospital Münster (DE)
- Centre National de la Recherche Scientifique (FR)
- Max Planck Institute for Molecular Biomedicine (DE)
- Montreal Neurological Institute and Hospital (CA)
- Medizinische Hochschule Hannover (DE)
- McGill University (CA)
- Center for Regenerative Therapies Dresden (DE)
- University of Münster (DE)
- INSERM, U1127, F-75013 Paris, France;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-02-28
- Volume
- 114
- Issue
- 11
- Pages
- E2243-E2252
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5358375
- OpenAlex
- W2592644893
- Cited by
- 257
- References
- 51
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 26 · 2023: 25 · 2022: 39 · 2021: 28 · 2020: 35 · 2019: 31 · 2018: 19 · 2017: 5
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-INBS-0011)
- National Institute of Neurological Disorders and Stroke (R25NS070697)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- oligodendrocyte differentiation, induced pluripotent stem cells, transcription factors, SOX10, Olig2, NKX6-2, myelination, myelin diseases, demyelination, neural progenitor cells, disease modeling, drug discovery screening
- MeSH terms
- Ectopic Gene Expression, Animals, Brain, Cell Differentiation, Cells, Cultured, Demyelinating Diseases, Disease Models, Animal, Myelin Basic Protein, Humans, Mutation, Myelin Sheath, Oligodendroglia, Spinal Cord, Transcription Factors, Biomarkers, Cluster Analysis, tau Proteins, Cell Death, Oxidative Stress, Cell Lineage, Gene Expression Profiling, Mice, Induced Pluripotent Stem Cells, Neural Stem Cells, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review